Key facts
- It has raised $770K; the latest was Early Stage VC ($470K) in Mar 2025.
- Notable investors include Aurelia Ventures, IITStartups.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for EnlitenAI
- ·The full record, as it builds
Funding rounds
No funding rounds for EnlitenAI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EnlitenAI
Developer of a cloud-based clinical decision support platform designed to integrate neurological indicators from wearable and implantable devices to inform personalized treatment decisions. The company offers a device-agnostic, context-aware platform that aggregates and augments multimodal data from third-party devices, enabling neurologists to deliver proactive, personalized neurological and neurobehavioral care through informed clinical decisions.
- Sector
- Healthcare
- HQ
- Tracy, CA, United States
- Founded
- 2020
- Employees
- 8
- Website
- enlitenai.com/
- Ownership
- Privately Held (backing)
EnlitenAI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EnlitenAI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EnlitenAI in its N-PORT filings yet. We sweep new filings monthly.